Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V, Pierangeli S, Milano F, Gionfriddo I, Brunetti L, Martelli MP, Falini B. Ranieri R, et al. Among authors: sciabolacci s. Leukemia. 2022 Oct;36(10):2351-2367. doi: 10.1038/s41375-022-01666-2. Epub 2022 Aug 25. Leukemia. 2022. PMID: 36008542 Free PMC article. Review.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Venanzi A, Marra A, Schiavoni G, Milner SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L, Pucciarini A, Falini L, Sciabolacci S, Martelli MP, Sportoletti P, Ascani S, Falini B, Tiacci E. Venanzi A, et al. Among authors: sciabolacci s. Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10. Blood Cancer Discov. 2021. PMID: 34164626 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34233286
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation.
Mancusi A, Zorutti F, Ruggeri L, Bonato S, Tricarico S, Zei T, Iacucci Ostini R, Viglione V, Sembenico R, Sciabolacci S, Cardinali V, Martelli MF, Mecucci C, Carotti A, Martelli MP, Velardi A, Pierini A. Mancusi A, et al. Among authors: sciabolacci s. Int J Mol Sci. 2023 Nov 9;24(22):16105. doi: 10.3390/ijms242216105. Int J Mol Sci. 2023. PMID: 38003295 Free PMC article.
One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, Quintini M, Matteucci C, Venanzi A, Tiacci E, Ascani S, Mecucci C, Martelli MP. Martino G, et al. Among authors: sciabolacci s. Ann Hematol. 2023 Oct;102(10):2969-2971. doi: 10.1007/s00277-023-05377-1. Epub 2023 Jul 22. Ann Hematol. 2023. PMID: 37481474 No abstract available.
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure.
Sartor C, Brunetti L, Audisio E, Cignetti A, Zannoni L, Cristiano G, Nanni J, Ciruolo R, Zingarelli F, Ottaviani E, Patuelli A, Bandini L, Forte D, Sciabolacci S, Cardinali V, Papayannidis C, Cavo M, Martelli MP, Curti A. Sartor C, et al. Among authors: sciabolacci s. Br J Haematol. 2023 Aug;202(3):599-607. doi: 10.1111/bjh.18887. Epub 2023 May 24. Br J Haematol. 2023. PMID: 37226312
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia.
Massei MS, Capolsini I, Mastrodicasa E, Perruccio K, Arcioni F, Cerri C, Gurdo G, Sciabolacci S, Falzetti F, Zei T, Iacucci Ostini R, Brogna M, Panizza BM, Saldi S, Merluzzi M, Tognellini R, Marchesi M, Minelli O, Aristei C, Velardi A, Pierini A, Ruggeri L, Martelli MF, Carotti A, Caniglia M. Massei MS, et al. Among authors: sciabolacci s. Bone Marrow Transplant. 2023 May;58(5):526-533. doi: 10.1038/s41409-023-01911-x. Epub 2023 Feb 11. Bone Marrow Transplant. 2023. PMID: 36774432 Free PMC article.